Oslo, Norway, 9 May 2003.
Galderma will today host a launch symposium for 30 selected opinion leaders in the UK for Metvix® PDT, PhotoCure's novel photodynamic therapy for the treatment of actinic keratosis and basal cell carcinoma. Galderma is PhotoCure's marketing partner for Metvix® PDT outside of the Nordic countries. The symposium is being held in Seville, in connection with the World Congress on Cancers of the Skin. Yesterday, Galderma hosted a satellite symposium for Metvix® PDT at the Congress with almost 300 participants.
The symposium will be followed by local launch events in the UK and training of dermatologists. Galderma has established several educational centres in the UK to ensure solid theoretical and practical training of doctors who wish to start practising PDT. Another key element of ensuring the commercial success of Metvix® PDT in the UK is Galderma's programme of equipping clinical centres with the Aktilite(TM) light sources supplied by PhotoCure.
The UK will be the second market in which Galderma has launched Metvix® PDT, the product was introduced to the German market in February 2003.